
WHO WE ARE
At Bio Strategy Advisors we are a team of seasoned professionals with more than 55 years of combined experience in BioPharma and MedTech. We have all had leadership roles in small startups, medium and large Biotech and MedTech companies.
OUR AREAS OF EXPERTISE:
-
Corporate Strategy
-
Commercial Strategy
-
​Go-To-Market and Global Product Launch Planning.
-
​Geographical Expansion
-
Strategic Alliances and Licensing
-
Product Portfolio Expansion
-
Business Opportunity Sizing​​​
​
-
Market Access, Pricing and Reimbursement
- Scientific and R&D support
-
Science and Technology Assessment
-
​Pipeline Prioritization
-
Data Gap Assessment
-
IND preparation
-
Regulatory and CMC support​​​​
OUR TEAM
Carolina Alarco
​Founder and Principal, Bio Strategy Advisors LLC
Co-Founder, Latinos in Bio
Carolina Alarco has more than 30 years of experience in the BioPharma industry in Massachusetts. Carolina has built a reputation for building Life Sciences companies and strategically developing markets for rare diseases and innovative technologies globally and successfully launching several transformative therapies. She founded Bio Strategy Advisors in 2019 and co-founded Latinos in Bio, in 2021 (a 501(c)(3) non-profit organization of Latino/a professionals in BioPharma). Carolina is a Board Member at MassBio, the Massachusetts Industry Council, and she serves on the board of several Biotech companies. She is a dynamic, global, and well-regarded senior executive in the life sciences industry with a keen business and financial acumen and a relentless focus on execution and delivering results.


Fernanda Gamero
​
Marketing Specialist and Project Coordinator, Bio Strategy Advisors LLC
Fernanda Gamero has been with Bio Strategy for about 4 years. She is instrumental in all aspects of Commercial and Marketing Planning and Execution. She specializes in Primary and Secondary Market Research, Logo creation and Branding elements and guidelines, Deck creation and polishing, Website design and Social Media presence development, and project coordination. She is also the Marketing Specialist for Latinos in Bio, a 501(c)(3) non-profit with over 1,200 members, dedicated to amplifying the social capital of Latino/a professionals in BioPharma and the Life Sciences. She has a keen eye for graphic design, wonderful organizational skills and a superb focus on execution.
Martin Williams
​
Strategic Consultant, Bio Strategy Advisors LLC
CEO and Founder, Syte.bio
CEO and Founder, Healix Instruments
Martin Williams has more than 20 years of experience in biotech, specializing in Cell and Gene Therapy, Synthetic Biology. He has been a Strategic Consultant at Bio Strategy for almost 2 years and is instrumental when it comes to assessing the scientific value of a technology, providing guidance on the R&D approach from discovery, to pre-clinical and clinical stages. Martin is the CEO and Founder of one of Bio Strategy's companies, SYTE.bio, a biotech start-up with next-generation innovative proprietary nucleic acid-based technologies (DNA and RNA) and has also founded Healix Instruments, a medical device company. He is a key partner for start-up founders during the drug or device development process, AI and data processing and pipeline prioritization.


Pablo Medina
​
Strategic Consultant, Bio Strategy Advisors LLC
Pricing/Market Access Expert, Financial Modeler
Pablo Medina brings over 17 years of global experience in Biotech, Pharma, and Diagnostics across Roche and Genentech. He has worked in roles of increasing responsibilities in the U.S. Commercial Organization, leading Access Strategy, Pricing, Contracting, and Distribution and in customer-facing roles interacting with Large U.S. payers. He has led financial valuations and market fit assessments for early pipeline products. He has also had stints in LATAM as Head of Health Policy and Patient Advocacy for Latin America, engaging directly with policymakers and relevant stakeholders in Access and Reimbursement matters. He also has deep expertise in Operations having led Supply Chain, planning, and Forecasting operations in LATAM, Europe, and the U.S. Pablo is recognized for driving innovative solutions, focusing on value-added outcomes, and driving global projects.

Pablo Medina
​
Strategic Consultant, Bio Strategy Advisors LLC
Pricing/Market Access Expert, Financial Modeler
Pablo Medina brings over 17 years of global experience in Biotech, Pharma, and Diagnostics across Roche and Genentech. He has worked in roles of increasing responsibilities in the U.S. Commercial Organization, leading Access Strategy, Pricing, Contracting, and Distribution and in customer-facing roles interacting with Large U.S. payers. He has led financial valuations and market fit assessments for early pipeline products. He has also had stints in LATAM as Head of Health Policy and Patient Advocacy for Latin America, engaging directly with policymakers and relevant stakeholders in Access and Reimbursement matters. He also has deep expertise in Operations having led Supply Chain, planning, and Forecasting operations in LATAM, Europe, and the U.S. Pablo is recognized for driving innovative solutions, focusing on value-added outcomes, and driving global projects.

Pablo Medina
​
Strategic Consultant, Bio Strategy Advisors LLC
Pricing/Market Access Expert, Financial Modeler
Pablo Medina brings over 17 years of global experience in Biotech, Pharma, and Diagnostics across Roche and Genentech. He has worked in roles of increasing responsibilities in the U.S. Commercial Organization, leading Access Strategy, Pricing, Contracting, and Distribution and in customer-facing roles interacting with Large U.S. payers. He has led financial valuations and market fit assessments for early pipeline products. He has also had stints in LATAM as Head of Health Policy and Patient Advocacy for Latin America, engaging directly with policymakers and relevant stakeholders in Access and Reimbursement matters. He also has deep expertise in Operations having led Supply Chain, planning, and Forecasting operations in LATAM, Europe, and the U.S. Pablo is recognized for driving innovative solutions, focusing on value-added outcomes, and driving global projects.
Veronica Gibaja
​
Strategic Consultant, Bio Strategy Advisors LLC
Pre-Clinical Pharmacology & IND Expert
Veronica Gibaja brings over 20 years of experience in drug discovery and early development within pharma and biotech organizations. She specializes in advancing pre-clinical programs with transformative potential, addressing unmet medical needs, and integrating patient stratification strategies. Veronica has played a pivotal role in identifying, characterizing, and advancing numerous drug candidates through early development, leading cross-functional R&D teams, and delivering comprehensive non-clinical pharmacology packages critical for IND applications and first-in-human clinical trials. Notably, she contributed to the development of Tazverik® (a first-in-class EZH2 inhibitor), FDA-approved for follicular lymphoma and epithelial sarcoma, and its expansion into additional indications. She excels in developing Target Product Profiles (TPPs), conducting gap analyses for IND readiness, and performing due diligence on innovative startup grant applications in a wide array of therapeutic modalities, including small molecules, proteins, antibody-drug conjugates (ADC), and gene and cell therapies and indications such as oncology, rare diseases, neurodegenerative disorders, metabolic diseases, and inflammatory conditions. She is also an advisor to Spectrus on the integration of cellular assays with proteomics, metabolomics, and glycomics to accelerate drug discovery and partnering efforts. Veronica mentors startups through programs such as the Mass Innovation Network, BrightEdge (American Cancer Society Venture) and Nucleate.
